1. Home
  2. UNB vs ARMP Comparison

UNB vs ARMP Comparison

Compare UNB & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Union Bankshares Inc.

UNB

Union Bankshares Inc.

N/A

Current Price

$24.49

Market Cap

107.6M

Sector

Finance

ML Signal

N/A

Logo Armata Pharmaceuticals Inc.

ARMP

Armata Pharmaceuticals Inc.

HOLD

Current Price

$7.89

Market Cap

125.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UNB
ARMP
Founded
1891
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
107.6M
125.7M
IPO Year
1998
N/A

Fundamental Metrics

Financial Performance
Metric
UNB
ARMP
Price
$24.49
$7.89
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$12.00
AVG Volume (30 Days)
17.7K
29.5K
Earning Date
01-16-2026
11-12-2025
Dividend Yield
6.08%
N/A
EPS Growth
27.30
N/A
EPS
2.47
N/A
Revenue
$52,533,000.00
$5,054,000.00
Revenue This Year
N/A
$4.48
Revenue Next Year
N/A
N/A
P/E Ratio
$9.60
N/A
Revenue Growth
13.25
N/A
52 Week Low
$20.65
$0.90
52 Week High
$36.00
$16.34

Technical Indicators

Market Signals
Indicator
UNB
ARMP
Relative Strength Index (RSI) 63.27 64.63
Support Level $23.32 $5.87
Resistance Level $24.32 $6.60
Average True Range (ATR) 0.65 0.52
MACD 0.06 0.09
Stochastic Oscillator 77.15 89.55

Price Performance

Historical Comparison
UNB
ARMP

About UNB Union Bankshares Inc.

Union Bankshares Inc operates as a community bank in the financial services industry. It offers retail and commercial banking services to its customers through its branches, ATMs, telebanking, and internet banking systems. The company provides retail banking services to individuals and commercial banking services to small and medium-sized corporations, partnerships, and sole proprietorships, as well as nonprofit organizations, local municipalities, and school districts within its market area. In addition, it also offers fiduciary and asset management services through its Asset Management Group.

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.

Share on Social Networks: